Harnessing the Gut–Immune–Brain Axis to Treat Disease
How a 100-year-old study spawned a novel class of multifunctional neurological treatments.
Read the latest on Bloom Science’s epilepsy and ALS lead programs and how a 100-year-old study spawned a novel class of multifunctional neurological treatments via our Nature Biopharma Dealmakers article.
![](https://bloomscience.com/wp-content/uploads/2022/12/Screen-Shot-2022-12-21-at-4.13.08-PM-1-1024x548.png)